Saturday, 11th February 29th Lorne Cancer Conference 2017

• Targeting the ribosome as a strategy to treat cancer - Rick Pearson
• Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer - Luke Selth
• Transient tissue ‘priming’ via ROCK manipulation uncouples pancreatic cancer progression, sensitivity to chemotherapy and the onset of the metastatic niche. - Claire Vennin
• PRMT5 - the great ocean road from target to drug to clinic - David Curtis

• Cancer nanomedicine: drug delivery and beyond to solid tumours - Maria Kavallaris
• Response and Resistance to PD1 inhibition - Helen Rizos
• Large scale chromosomal changes dominate the genomic landscape of end stage melanoma - Ismael A Vergara
• Genomic and epigenomic profiles of Asian endemic cancers - Patrick Tan

• Tackling the new face of prostate cancer: Exploring novel patho-phenotypes of drug resistant disease - Amina Zoubeidi
• The dual inhibition of RNA Pol I transcription and PIM kinase as a new therapeutic approach to treat advanced prostate cancer - Luc Furic
• Germline BRCA2 Mutations Drive Prostate Cancers with Increased Genomic Instability and Distinct Evolutionary Trajectories - Renea A Taylor
• Pericytes as microenvironmental regulators of normal and neoplastic epithelia. - Pritinder Kaur

• Therapy of Lymphoma Inspired by Functional and Structural Genomics - Louis Staudt

After dinner speaker -

Emeritus Prof Simon Chapman AO PhD FASSA HonFFPH(UK) – “how to grow rhino hide”